Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review

A. Effinger; C.M. O'Driscoll; M. McAllister; N. Fotaki

doi:10.1111/jphp.12928

Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review

A. Effinger
, C.M. O'Driscoll
, M. McAllister
, N. Fotaki

School of Pharmacy

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of Pharmacy and Pharmacology
DOIs	https://doi.org/10.1111/jphp.12928
Publication status	Published - 2019

Access to Document

10.1111/jphp.12928

Cite this

@article{bfc3746cd9a243b9b26be86423dccba0,

title = "Impact of gastrointestinal disease states on oral drug absorption {\textendash} implications for formulation design {\textendash} a PEARRL review",

author = "A. Effinger and C.M. O'Driscoll and M. McAllister and N. Fotaki",

year = "2019",

doi = "10.1111/jphp.12928",

language = "English",

journal = "Journal of Pharmacy and Pharmacology",

issn = "0022-3573",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review

AU - Effinger, A.

AU - O'Driscoll, C.M.

AU - McAllister, M.

AU - Fotaki, N.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85060517973&partnerID=MN8TOARS

U2 - 10.1111/jphp.12928

DO - 10.1111/jphp.12928

M3 - Article

SN - 0022-3573

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

ER -

Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review

Access to Document

Other files and links

Cite this